Opioid-Induced Constipation Treatment Market 2024 - By Industry Analysis, Future Prediction, Business Overview And Forecast To 2033
Opioid-induced constipation (OIC)
treatment refers to the various approaches and medications used to manage
constipation caused by the use of opioid medications. These treatments aim to
alleviate the symptoms of constipation without compromising the pain-relieving
effects of opioids, thereby improving the patient's overall quality of life and
maintaining effective pain management with both pharmacological with
non-pharmacological approaches.
Sizing and Forecast
The opioid-induced constipation
treatment market size has grown strongly in recent years. It will grow from
$1.66 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate
(CAGR) of 6.7%. The growth in the historic period can be attributed to
expanding geriatric population, personalized OIC treatments, availability of
effective OIC drugs, increasing prevalence of opioid use, and rising prevalence
of gastrointestinal disorders.
The opioid-induced constipation
treatment market size is expected to see strong growth in the next few years.
It will grow to $2.31 billion in 2028 at a compound annual growth rate (CAGR)
of 6.8%. The growth in the forecast
period can be attributed to accelerated drug approval initiatives, increasing
use of opioid analgesic prescriptions, surging expenditure on the R And D of
novel treatments, and an increase in development of biologics. Major trends in
the forecast period include patient education and awareness, the emergence of
targeted therapies, non-pharmacological interventions, biotechnology
innovations, and increased investment.
Order your report now for swift
delivery, visit the link:
Segmentation & Regional
Insights
The opioid-induced constipation
treatment market covered in this report is segmented –
1) By Drug Class:
Laxatives, Peripherally Acting μ-opioid Receptor Antagonists, Serotonin
Receptor Agonists, Prostaglandin
2) By Type: Oral,
Parenteral
3) By Distribution Channel:
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
North America was the largest
region in the opioid-induced constipation treatment market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the opioid-induced constipation treatment market
report are Asia-Pacific, Western Europe, Eastern Europe, North America, South
America, Middle East and Africa.
Intrigued to explore the
contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15881&type=smp
Major Driver Impacting Market
Growth
The rise in the administration of
opioids for cancer and non-cancer pain is expected to propel the growth of the
opioid-induced constipation treatment market going forward. Cancer pain refers
to pain associated with cancer and its treatment, while non-cancer pain refers
to pain from conditions unrelated to cancer. Administration of opioids for
cancer and non-cancer pain is driven by the need to effectively manage moderate
to severe pain, considering factors such as the intensity and duration of pain,
patient response to other treatments, and the overall goal of improving quality
of life while minimizing potential risks of addiction and side effects.
Opioid-induced constipation (OIC) treatment helps patients with cancer and
non-cancer pain by relieving constipation caused by opioid use, thereby
improving overall comfort, adherence to pain management regimens, and quality
of life without compromising pain relief. For instance, in April 2023,
according to the Center for Disease Control and Prevention (CDC), a US-based
national public health agency, during 2021, approximately 20.9% of U.S. adults
(51.6 million people) reported experiencing chronic pain, and 6.9% (17.1
million people) experienced high-impact chronic pain, which significantly
limits daily activities. Therefore, the rise in the administration of opioids
for cancer and non-cancer pain is driving the growth of the opioid-induced
constipation treatment market.
Key Industry Players
Major companies operating in the
opioid-induced constipation treatment market are Pfizer Inc., Merck & Co.
Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company
Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., Bausch Health Companies Inc.,
Boehringer Ingelheim International GmbH., Shionogi & Co. Ltd., Ono
Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals
plc, Mundipharma International Limited, Lantheus Holdings Inc., Indivior plc,
Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc., Ironwood
Pharmaceuticals Inc., Cosmo Pharmaceuticals SA, Nektar Therapeutics, RedHill
Biopharma Ltd., Theravance Biopharma Inc., Cumberland Pharmaceuticals Inc.,
Valinor Pharma LLC
The opioid-induced constipation
treatment market report table of contents includes:
1. Executive Summary
2. Opioid-Induced Constipation
Treatment Market Characteristics
3. Opioid-Induced Constipation
Treatment Market Trends And Strategies
4. Opioid-Induced Constipation
Treatment Market - Macro Economic Scenario
5. Global Opioid-Induced
Constipation Treatment Market Size and Growth
.............................
32. Global Opioid-Induced
Constipation Treatment Market Competitive Benchmarking
33. Global Opioid-Induced
Constipation Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions
In The Opioid-Induced Constipation Treatment Market
35. Opioid-Induced Constipation
Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment